Manchester Capital Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-72
Closed -$1.28K – 1036
2023
Q2
$1.28K Buy
72
+52
+260% +$882 ﹤0.01% 786
2023
Q1
$356 Sell
20
-54
-73% -$1.01K ﹤0.01% 1031
2022
Q4
$1.45K Hold
74
– – ﹤0.01% 752
2022
Q3
$1K Sell
74
-23
-24% -$465 ﹤0.01% 841
2022
Q2
$2K Sell
97
-45
-32% -$1.06K ﹤0.01% 745
2022
Q1
$4K Sell
142
-96
-40% -$2.64K ﹤0.01% 704
2021
Q4
$7K Hold
238
– – ﹤0.01% 621
2021
Q3
$6K Buy
+238
New +$6.37K ﹤0.01% 662
2016
Q2
– Sell
-4,228
Closed -$111K – 573
2016
Q1
$111K Buy
+4,228
New +$97.9K 0.02% 282

Other funds holding TBI

Manchester Capital Management's TBI Position: Q3 2023 in Review

Manchester Capital Management sold out of Trueblue (TBI) in Q3 2023, closing a stake of 72 shares — an estimated $1.28K sold.

Manchester Capital Management first reported a position in TBI in Q1 2016 and held it in 9 quarters. The position peaked at $111K in Q1 2016. 144 funds tracked by Wall St. Rank hold TBI as of Q3 2023.

  • Manchester Capital Management reported no remaining Trueblue position as of Q3 2023 after selling out during the quarter.
  • Manchester Capital Management sold 72 Trueblue shares in Q3 2023, an estimated $1.28K.
  • Manchester Capital Management first reported a position in Trueblue in Q1 2016 and held it in 9 quarters.
  • Manchester Capital Management's Trueblue position peaked at $111K in Q1 2016.
  • 144 funds tracked by Wall St. Rank held Trueblue as of Q3 2023.

Based on Manchester Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.